Glatiramyl 20 mg/ml, Injektionslösung in einer Fertigspritze

7680656260015 CH-65626 Injektionslösung
Glatiramyl 20 mg/ml, Injektionslösung in einer Fertigspritze
Glatiramyl 20 mg/ml, Injektionslösung in einer Fertigspritze
Glatiramyl 20 mg/ml, Injektionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/04/2025
Patient information leaflet
Français
10/04/2025
Patient information leaflet
Italien
10/04/2025
Summary of Product Characteristics
Allemand
10/04/2025
Summary of Product Characteristics
Français
10/04/2025
Summary of Product Characteristics
Italien
10/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance WIZUS
(N/A)
18.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 728.00
Specialties list
Yes
Generic
Yes
SL addition date: 01/12/2016

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
65626
Drug name
Glatiramyl 20 mg/ml, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L03AX13
Authorization status
Z
Dispensing category
B
First authorization
05/07/2016
Authorization expiration date
31/12/9999
IT Number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Package details

Description (FR)
GLATIRAMYL sol inj 20 mg/ml 28 ser pré 1 ml
Description (DE)
GLATIRAMYL Inj Lös 20 mg/ml 28 Fertspr 1 ml
Market launch
05/07/2016
Narcotic (BTM)
No

Original drug

Copaxone, Injektionslösung in einer Fertigspritze
GTIN: 7680563630024
CHF 855.90
View original